GlassScriptPhysician profile
Jonathan Spagnola
NPI 1205275526
$26,632.97
in general payments reported to CMS, 2019-2025
19 companies · $4,569 in 2025
The $4,569 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $24.92 · 2021: $3,944 · 2022: $1,058 · 2023: $1,597 · 2024: $15K · 2025: $4,569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Food and Beverage: $4,340 · Education: $1,121 · Consulting Fee: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,595.64 |
| Food and Beverage | $4,340.09 |
| Education | $1,120.74 |
| Consulting Fee | $550.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $17,876.25 | 2023-2025 | Ffrct |
| Abiomed | $1,938.44 | 2021-2023 | Impella |
| Medtronic, INC. | $1,445.48 | 2021-2024 | Corevalve Evolut R, Onyx Frontier, Ffrangio |
| Boston Scientific Corporation | $1,013.22 | 2021-2025 | Synergy, Avvigo Guidance System, Rotapro |
| Philips North America LLC | $935.92 | 2021-2024 | (Bq9) Coronary Ivus |
| Cardiovascular Systems INC. | $799.28 | 2021 | |
| Shockwave Medical, INC | $754.16 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $505.56 | 2021-2025 | Mitraclip, Optis, Perclose Proglide |
| Spectrawave, INC | $323.28 | 2024-2025 | Starlight Imaging Catheter, Hypervue Imaging System |
| Saranas, INC. | $215.63 | 2022 | |
| Penumbra, INC. | $196.99 | 2021 | |
| Janssen Pharmaceuticals, INC | $185.87 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $118.24 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.99 | 2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $66.85 | 2021-2024 | Wainua |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $53.70 | 2020-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.84 | 2022 | |
| Angiodynamics, INC. | $30.45 | 2021 | |
| Teleflex LLC | $22.82 | 2023 | Guideliner |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Spagnola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.